706 related articles for article (PubMed ID: 19398594)
1. MicroRNA involvement in the pathogenesis and management of breast cancer.
Khoshnaw SM; Green AR; Powe DG; Ellis IO
J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
Shi M; Guo N
Cancer Treat Rev; 2009 Jun; 35(4):328-34. PubMed ID: 19171434
[TBL] [Abstract][Full Text] [Related]
3. MicroRNAs: novel regulators in the hallmarks of human cancer.
Ruan K; Fang X; Ouyang G
Cancer Lett; 2009 Nov; 285(2):116-26. PubMed ID: 19464788
[TBL] [Abstract][Full Text] [Related]
4. Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs.
Wu M; Jolicoeur N; Li Z; Zhang L; Fortin Y; L'Abbe D; Yu Z; Shen SH
Carcinogenesis; 2008 Sep; 29(9):1710-6. PubMed ID: 18356149
[TBL] [Abstract][Full Text] [Related]
5. MicroRNAs in breast cancer pathogenesis.
Götte M
Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA profiling as a tool to understand prognosis, therapy response and resistance in breast cancer.
Iorio MV; Casalini P; Tagliabue E; Ménard S; Croce CM
Eur J Cancer; 2008 Dec; 44(18):2753-9. PubMed ID: 19022662
[TBL] [Abstract][Full Text] [Related]
7. Multi-class cancer classification through gene expression profiles: microRNA versus mRNA.
Peng S; Zeng X; Li X; Peng X; Chen L
J Genet Genomics; 2009 Jul; 36(7):409-16. PubMed ID: 19631915
[TBL] [Abstract][Full Text] [Related]
8. Implications of micro-RNA profiling for cancer diagnosis.
Cummins JM; Velculescu VE
Oncogene; 2006 Oct; 25(46):6220-7. PubMed ID: 17028602
[TBL] [Abstract][Full Text] [Related]
9. Role of miRNA in carcinogenesis and biomarker selection: a methodological view.
Ahmed FE
Expert Rev Mol Diagn; 2007 Sep; 7(5):569-603. PubMed ID: 17892365
[TBL] [Abstract][Full Text] [Related]
10. MicroRNAs as prognostic indicators and therapeutic targets: potential effect on breast cancer management.
Lowery AJ; Miller N; McNeill RE; Kerin MJ
Clin Cancer Res; 2008 Jan; 14(2):360-5. PubMed ID: 18223209
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs and cancer.
Cowland JB; Hother C; Grønbaek K
APMIS; 2007 Oct; 115(10):1090-106. PubMed ID: 18042145
[TBL] [Abstract][Full Text] [Related]
12. The utility of LNA in microRNA-based cancer diagnostics and therapeutics.
Stenvang J; Silahtaroglu AN; Lindow M; Elmen J; Kauppinen S
Semin Cancer Biol; 2008 Apr; 18(2):89-102. PubMed ID: 18295505
[TBL] [Abstract][Full Text] [Related]
13. Identification of differentially expressed microRNAs by microarray: a possible role for microRNA genes in pituitary adenomas.
Bottoni A; Zatelli MC; Ferracin M; Tagliati F; Piccin D; Vignali C; Calin GA; Negrini M; Croce CM; Degli Uberti EC
J Cell Physiol; 2007 Feb; 210(2):370-7. PubMed ID: 17111382
[TBL] [Abstract][Full Text] [Related]
14. Expression profiling of microRNAs in cancer cells: technical considerations.
Sioud M; Cekaite L
Methods Mol Biol; 2008; 439():179-90. PubMed ID: 18370103
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA expression profiling in cancer from a bioinformatics prospective.
Gusev Y; Brackett DJ
Expert Rev Mol Diagn; 2007 Nov; 7(6):787-92. PubMed ID: 18020908
[TBL] [Abstract][Full Text] [Related]
16. The roles of microRNA in cancer and apoptosis.
Lynam-Lennon N; Maher SG; Reynolds JV
Biol Rev Camb Philos Soc; 2009 Feb; 84(1):55-71. PubMed ID: 19046400
[TBL] [Abstract][Full Text] [Related]
17. Kallikreins as microRNA targets: an in silico and experimental-based analysis.
Chow TF; Crow M; Earle T; El-Said H; Diamandis EP; Yousef GM
Biol Chem; 2008 Jun; 389(6):731-8. PubMed ID: 18627289
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA (miRNA) cloning analysis reveals sex differences in miRNA expression profiles between adult mouse testis and ovary.
Mishima T; Takizawa T; Luo SS; Ishibashi O; Kawahigashi Y; Mizuguchi Y; Ishikawa T; Mori M; Kanda T; Goto T; Takizawa T
Reproduction; 2008 Dec; 136(6):811-22. PubMed ID: 18772262
[TBL] [Abstract][Full Text] [Related]
19. Investigation of microRNA alterations in leukemias and lymphomas.
Calin GA; Croce CM
Methods Enzymol; 2007; 427():193-213. PubMed ID: 17720486
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.
Meyer-Rochow GY; Jackson NE; Conaglen JV; Whittle DE; Kunnimalaiyaan M; Chen H; Westin G; Sandgren J; Stålberg P; Khanafshar E; Shibru D; Duh QY; Clark OH; Kebebew E; Gill AJ; Clifton-Bligh R; Robinson BG; Benn DE; Sidhu SB
Endocr Relat Cancer; 2010 Sep; 17(3):835-46. PubMed ID: 20621999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
